Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual

AIDS. 1999 Oct 22;13(15):2171-3. doi: 10.1097/00002030-199910220-00024.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Anti-HIV Agents / therapeutic use*
  • Drug Therapy, Combination
  • HIV Envelope Protein gp41 / chemistry*
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors
  • Humans
  • Male
  • Middle Aged
  • Nelfinavir
  • Nevirapine
  • Peptides / chemistry*
  • Peptides / therapeutic use*
  • Reverse Transcriptase Inhibitors
  • Saquinavir

Substances

  • Anti-HIV Agents
  • HIV Envelope Protein gp41
  • HIV Protease Inhibitors
  • Peptides
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • Nelfinavir
  • Saquinavir